An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol.

NeuropsychopharmacologyMay 20, 2026 (epub)
Clinical ResearchPsychiatryOpen access

Gabriel P A Costa, Mehmet Sofuoglu, Peggy Compton et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the effects of cannabidiol (CBD) on pain modulation, craving, and cognition in 23 individuals with opioid use disorder (OUD) and chronic pain receiving opioid agonist treatment (OAT). Results indicated that CBD enhanced descending pain inhibition pre-OAT, with a significant linear dose-response observed at 800 mg and 1200 mg (p = 0.034). However, post-OAT, 1200 mg CBD worsened heat pain sensitivity compared to placebo (p = 0.017).

Key findings

  • CBD enhanced descending pain inhibition pre-OAT with a significant linear dose-response (p = 0.034).
  • At 1200 mg post-OAT, CBD significantly reduced heat pain threshold compared to placebo (p = 0.017).
  • CBD showed no significant effects on opioid craving.
  • Cognitive performance remained stable across all CBD doses.

Why it matters

Understanding the effects of CBD in patients with co-occurring OUD and chronic pain is crucial, as it may inform non-opioid adjunct therapies. The phase-dependent effects observed suggest that timing of CBD administration relative to OAT is important for optimizing pain management.

Source

PubMed · PMID 42162267Free full text on PubMed Central

Published in Neuropsychopharmacology. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.